Eric Adam Email and Phone Number
(Always happy to meet new people! but send me a short intro note) 15+ years of experience in strategic planning and leadership roles:-Led global transformation initiatives for Roche, ensuring effective portfolio execution and innovation with external partners and Roche group companies.-Over 10 years of experience driving patient-centric public-private partnerships and multi-stakeholder alliances, delivering business results and global market access to life-saving medicines.Passion to lead and develop high-performing teams:-Successfully launched and managed three organizations in the antimicrobial resistance space, including two biotechnology start-ups and a non-profit organization.-Played a key role in the development and launch of life-saving diagnostic tests in 27 low-and middle income countries.-Expertise in navigating complex organizational dynamics and collaborating with senior stakeholders-Collaborated with senior management at Roche, Otsuka Pharmaceuticals Japan, Syrrx (Takeda California), and the Bill & Melinda Gates Foundation-funded FIND organization.Effectively influenced decisions and built trust with C-level executives of large organizations.Successful track record in leading complex global-scale projects:-Led the transformation of Roche's pRED neuroscience DTA to new, more agile ways of working.-Managed complex global projects across functions and regions in the pharmaceutical, biotechnology, medical device, and non-profit sectors.Strong communication and presentation skills:-Effectively communicated complex technical information to diverse audiences, including scientists, physicians, and senior management.-Presented strategy and project plans to senior executives of Roche and other organizations.Transformed intricate concepts into readily consumable and actionable takeaways.Thriving in fast-paced, multicultural settings:-Flourished in international environments characterized by cultural diversity and rapid changeAim high, think big, take risks, be authentic, remain humble and deliver! That's my motto and I look forward to connecting with you.
-
Chief Operating OfficerHaya Therapeutics Jun 2024 - PresentLausanne - Switzerland / San Diego - Usa, ChFocus on several key areas to support HAYA's growth and development:1. Streamline operations and work to optimize HAYA's operational processes to facilitate scalable growth and international expansion2. Maintain leadership in RNA therapeutics and ensure that HAYA continues to be at the forefront of precision RNA-targeted therapeutics3. Support the development of strategic partnerships to enhance HAYA's capabilities and reach4. Contribute to the advancement of HAYA's product portfolio, including our lead therapeutic candidate HTX-0015. Overseeing core functions and managing various operational aspects, including: - Business development - Strategic collaborations - Human resources - Finance - Information technology - Communications - Quality assurance
-
Global Head @ Roche | Operational Excellence, NeuroscienceRoche Apr 2019 - May 2024Switzerland 🇨🇭 , ChCore Competencies:-Strategic partner for internal and external advisors to address complex scientific and corporate questions-Re-inventing neuroscience operations towards (1) portfolio prioritization, (2) management of external collaborations and partnerships and (3) process improvement-Mentoring and steering a large 190-member team towards organizational objectives-Implementing novel R&D processes and governance in support to head of R&D, exploring competitive landscapes-Translating molecule strategy to execution plans, keeping teams on track & removing obstacles-Providing portfolio insights for leadership and exploring external collaborations with KOLs and top science partners-Fostering strong collaborative relationships towards a group-wide OneRoche Neuroscience portfolio-Driving organizational growth, governance & culture reforms, and prioritized allocation of resources-Anticipating a rapidly changing global R&D environment, support to partnering & innovative AI solutions to drive R&D productivity upKey Achievements:-Through successful partnerships and initiatives, directly contributed to increased value within the neuroscience portfolio, including entries into the portfolio and technical successes in drug discovery-Refined neuroscience asset prioritization to create space for new ventures and efficient decision-making-Transformed leadership structures to improve communication, decision-making, and overall team culture that resulted in boosted performance and a collaborative environment -
Executive DirectorNext2People Aug 2015 - Mar 2019Core Competencies:-Managing innovative Public-Private Partnerships to expand access to primary healthcare in South Africa-Pioneering integrated protocols for diabetes and TB patient management, streamlining care delivery-Introducing diagnostic solutions for improved TB patient management and decision-makingKey Achievements:-Led the development of patient-centric PPPs, increasing access to primary care through private GPs-Established comprehensive guidelines and protocols for streamlined TB/diabetes patient care-Implemented Point of Care diagnostics solutions to enhance clinical decision-making and patient outcomes
-
Strategic Alliances DirectorOtsuka Sa Oct 2012 - Aug 2015Core Competencies:-Spearheading multi-stakeholder alliances to successfully bring Deltyba to market-Implementing strategic business plans and partnerships to drive financial and market access success-Ensuring regulatory compliance for Phase 2b/Phase 3 approvals including orphan drug designation, conditional approval, compassionate use and pediatric approvalKey Achievements:-Orchestrated alliances that drove Deltyba's approval, launch, and commercialization success-Achieved significant business objectives and expanded market reach through strategic alliances
-
Senior Implementation Officer & Regulatory AffairsFind, Foundation For Innovative New Diagnostics Feb 2007 - Sep 2012Le Grand-Saconnex, Geneva, ChCore Competencies:Strategic leadership and guidance for the development of novel in vitro diagnostics (IVDs) for TB detection-Navigating and concluding intricate multipartite negotiations for building sustainable local diagnostic ecosystems (co-development, in-licensing, country MoUs, tech transfer)-Overseeing device regulatory compliance through WHO and country own regulatory processes-Establishing and managing the supply chain for IVDs in 27 low- and middle-income countries including India-Leading ISO 9001/13485 certification requirements and GMP qualifications in Chinese/Japanese factoriesKey Achievements:-Ensured access to affordable, quality-controlled diagnostic tests in low- and middle-income countries, involving securing co-development agreements, IP, potential technology transfer, tiered pricing structures and distribution.-Played a pivotal role in the successful development and supply of TB-IVDs, establishing BSL3 laboratory capacity at 103 sites in 27 countries, enabling the enrollment and management of 125,000 MDR-TB patients (https://tinyurl.com/4mpvpb2k)-Achieved ISO 9001 and ISO 13485 certifications that increased reputation and grant application successes -
EntrepreneurBiosafetys Oct 2005 - Feb 2007Strategic and operational management of a medical device start-up initiative for the discovery of novel surface chemistry to prevent bacterial infections to develop on surgical implants
-
Director, Drug Discovery And DevelopmentAthelas, Sa Oct 2002 - Oct 2005Core Competencies:-Led HTS platform in a mammalian surrogate host model for the measurement of microbial virulence (https://pubmed.ncbi.nlm.nih.gov/17474906/)-Developed novel antimicrobials that prevent rise of resistance up to pre-clinical stage (CROs)-Led, mentored, and managed R&D department, microfluidic robotics and databasesKey Achievements:-Integrated platform technology, biology and software to enable HTS of ‘000 of small molecule compounds-Fostered external partner collaborations that accelerated timelines and improved cost-effectiveness
-
Structure-Based Drug Design, ScientistTakeda San Diego, Inc. (Ex. Syrrx, Inc.) Jul 2001 - Oct 2002Leveraging high-throughput protein structure determination using genomics, process development and protein purification in partnership with industry leaders (https://tinyurl.com/5xabu28f). Co-Inventor of the AKT3 structure (tinyurl.com/ynkvjj9m) towards novel cancer therapies
-
Scientist, Ruo Assay DevelopmentNew England Biolabs, Inc. Jun 1996 - Jun 2000Ipswich, Ma, UsGenomics, biochemistry and lab reagent development. Research Project Leader (PhD work) co-inventor of the ubiquitous auto-catalytic protein splicing mechanism in trans, developing protein purification and peptide-expressing phage display library toolkits. Inventor (https://tinyurl.com/243cjaxw) -
Research Project LeaderBiozentrum Der Universität Basel, Arber'S Nobel Lab Jun 1994 - Jun 1996Molecular biology & microbiology. Studying genetic variations impact on bacterial fitness
Eric Adam Education Details
-
Hec, Hautes Etudes CommercialesGeneral -
Centre Hospitalier Universitaire VaudoisCertification To Conduct Animal Studies
-
Paris-Sud University (Paris Xi)Bio-Medical
-
Ecole Supérieure De Biotechnologie De StrasbourgEsbs
Frequently Asked Questions about Eric Adam
What company does Eric Adam work for?
Eric Adam works for Haya Therapeutics
What is Eric Adam's role at the current company?
Eric Adam's current role is Chief Operating Officer | HAYA THERAPEUTICS | Lausanne / San Diego.
What schools did Eric Adam attend?
Eric Adam attended Hec, Hautes Etudes Commerciales, Centre Hospitalier Universitaire Vaudois, Paris-Sud University (Paris Xi), Ecole Supérieure De Biotechnologie De Strasbourg.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial